TNF and inflammatory bowel disease: Although the successful application of anti-TNF-α treatment was a major breakthrough in the treatment of IBD, approximately one-third of patients do not respond to anti-TNF-α treatment, and many others eventually lose responsiveness or become intolerant to these agents (Melmed & Targan, 2010).